This article is very consistent with what I saw on Fox Business this morning. The report I saw on Fox has retailers making shelf room right now for the next phase of CBD retailing which as we all know is the consumables.
These retailers that were named were CVS, Target, Walgreens, Wal Mart to name a few. If you listened very carefully to Dowlings remarks on the call, it is pretty obvious that CVSI is in the conversations with these retailers as we speak.
For those of you who follow the Yahoo board, and in particular captainjonesthe3rd you may have read his commentary about the hammer about to go down on a number of CBD companies who are clearly misrepresenting their product line for composition and amount of CBD in their respective pills or other ingestible items.
This "hammer" will happen after the FDA holds its hearings on May 31. Here is how I think it will go down:
If you are CBD mass distributor, you will need to send some sort of representation to the hearing. Not just corporate reps or VP's or marketing staff, but you are going to need to explain the traceability and the SCIENCE behind why your product is safe for the consumer. So you will need some expert scientific testimony to support your claims. The FDA is very concerned about the type of hemp being used for CBD production and they are concerned about the THC content in CBD from the marijuana plant itself.
For reputable companies such as CVSI, they will be able to explain the very need TO the FDA the reasoning for proof of safety and traceability of other CBD products. I am sure that McKay will explain the painstaking process of GRAS certification and why it needs to be done industry wide.
I believe the FDA at some point will come to the conclusion that an FDA approved testing facility or facilities will be named and your CBD products will need some sort of certification of safety to the public via of some sort of laboratory endorsement.
The basic premise of less than 0.3 THC content would be the constant for all CBD sold for consumption.
As far as other ingredients are concerned, that may not be that important to the FDA. What they are looking at is safety. You are going to have to scientifically prove the safety of your product.
I would also suspect that the FDA will put a number of companies on notice at that hearing. You can be assured that those who are violating FDA guidelines right now will need to be very careful going forward.
Although it is a hearing, don't underestimate the savvy nature of the FDA. The hearing will allow them to find out who the CBD players are and the general landscape of the "who's who" of the whole sale distribution networks.
If you listen to Stuart Tomc speak in the past about this issue, he has waited for this moment. No one is better prepared than we are.
Separation from the competition is what this will ultimately bring. If you are mass distributing CBD right now and don't show up at the hearing....you may be a dead distributor walking... and if you do show up you better know what the hell is in your product line and have the science to back it up.
In the end....the mass retailers are going to with safety and high proven quality. With the certifications and the CRN network as lobbying groups you can see we are in the sweet spot for this.
We have full traceability from seed to shelf. I don't know who else can make that claim.
AI
